PRAGUE, March 5, 2025 /CNW/ -- EMFACE, the revolutionary non-invasive facial treatment, has reached an extraordinary milestone—becoming the fastest procedure of its kind to surpass 1 million ...
BOSTON, Aug. 13, 2025 /CNW/ -- BTL Industries, a global leader in medical and wellness technologies, has expanded the FDA-cleared applications of its EMFACE® platform with a new indication for the ...
The breakthrough ExoTMS™ technology stimulates key brain areas, boosts neuroplasticity, and strengthens brain pathways. EXOMIND is FDA-cleared for depression in the United States, and also approved by ...
BOSTON--(BUSINESS WIRE)--BTL Industries, a leading manufacturer of devices for medical and aesthetic use, announced the FDA clearance of its groundbreaking BTL Vanquish device for circumferential ...
The BTL-6000 SWT power shockwave therapy from BTL is highly-effective, non-invasive treatment for pain associated with musculoskeletal system. Fast relief of pain & mobility restoration Main fields of ...
Hosted on MSN
BTL wins patent enforcement against WonderFace
PRAGUE, Jan. 22, 2026 /PRNewswire/ -- BTL Group, a global leader in medical technologies, today announced the successful resolution of multiple patent infringement proceedings against Lexter ...
Stoll Keenon Ogden filed a patent and trademark infringement lawsuit Wednesday in Indiana Southern District Court on behalf of BTL Industries Inc. for claims pertaining to BTL's non-invasive muscle ...
The breakthrough ExoTMS™ technology stimulates key brain areas, boosts neuroplasticity, and strengthens brain pathways. PRAGUE, Jan. 15, 2025 /PRNewswire/ -- BTL, the innovator in medical and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results